| Name | Title | Contact Details |
|---|
Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO). Headquartered in Stockholm, we employ nearly 5 000 people and the Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For over 20 years we have focussed on supporting pharmaceutical companies in taking their products from early development through to commercial manufacturing. Throughout the entire product lifecycle, we are there for our clients. Time and time again, we have delivered innovative solutions.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Aspenbio Pharma Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Castle Rock, CO. To find more information about Aspenbio Pharma Inc, please visit www.aspenbiopharma.com
Synvasive Technology Inc is a El Dorado Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nanoscale Combinatorial Synthesis, Inc. is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.